XML 37 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 19,878 $ 16,974
Net income from continuing operations 19,878 16,974
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 6,200 7,471
Amortization of debt issue costs 96 96
Provision for doubtful accounts 1,928 1,678
Share-based compensation 2,876 2,471
Deferred income taxes 2,079 2,433
Change in fair value of contingent consideration 314 0
Finance lease interest 15 25
Changes in operating assets and liabilities:    
Accounts receivable 79,010 20,606
Inventories (20,574) 9,524
Prepaid expenses and other assets 5,262 (1,952)
Other non-current assets 552 3,285
Accounts payable (70,297) (17,002)
Accrued expenses and other liabilities (3,758) 744
Income taxes payable (370) (1,523)
Net cash provided by operating activities 23,211 44,830
Cash flows from investing activities:    
Capital expenditures (2,395) (2,375)
Cash paid for business acquisitions, net of cash acquired 0 (56,849)
Net cash used in investing activities (2,395) (59,224)
Cash flows from financing activities:    
Borrowings on revolving credit 49,210 8,381
Repayments on revolving credit (49,210) (8,430)
Repayments on long-term debt (2,236) (357)
Repayments on finance lease obligation (271) (275)
Contingent consideration payments (1,375) 0
Exercise of stock options 4,834 6,971
Taxes paid on settlement of equity awards (2,617) (4,794)
Common stock repurchased, including excise tax (21,285) (28,126)
Net cash used in financing activities (22,950) (26,630)
Effect of exchange rate changes on cash and cash equivalents 901 608
Decrease in cash and cash equivalents (1,233) (40,416)
Cash and cash equivalents at beginning of period 126,157 185,460
Cash and cash equivalents at end of period $ 124,924 $ 145,044